UA102565C2 - Фармацевтическая композиция для системного лечения инвазии паразитов, которые сосут кровь или кормятся кровью, которая как антипаразитический препарат содержит имидаклоприд - Google Patents

Фармацевтическая композиция для системного лечения инвазии паразитов, которые сосут кровь или кормятся кровью, которая как антипаразитический препарат содержит имидаклоприд

Info

Publication number
UA102565C2
UA102565C2 UAA201105519A UAA201105519A UA102565C2 UA 102565 C2 UA102565 C2 UA 102565C2 UA A201105519 A UAA201105519 A UA A201105519A UA A201105519 A UAA201105519 A UA A201105519A UA 102565 C2 UA102565 C2 UA 102565C2
Authority
UA
Ukraine
Prior art keywords
blood
sucking
imidacloprid
invasion
pharmaceutical composition
Prior art date
Application number
UAA201105519A
Other languages
English (en)
Ukrainian (uk)
Inventor
Роланд Х. Джонсон
Дуглас И. Хеплер
Кетлин Г. Палма
Вильям Р. Кемпбелл
Original Assignee
Байер Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Б.В. filed Critical Байер Б.В.
Publication of UA102565C2 publication Critical patent/UA102565C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Фармацевтически приемлемые композиции на основе одного антипаразитического агента имидаклоприда для орального введения млекопитающим с целью системного контроля определенных паразитов, которые сосут кровь или кормятся кровью, таких как блохи, клещи, а также определенные виды гельминтов и возбудителей чесотки.
UAA201105519A 2008-10-03 2009-09-30 Фармацевтическая композиция для системного лечения инвазии паразитов, которые сосут кровь или кормятся кровью, которая как антипаразитический препарат содержит имидаклоприд UA102565C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10277408P 2008-10-03 2008-10-03
PCT/US2009/059111 WO2010039892A1 (en) 2008-10-03 2009-09-30 Systemic treatment of blood-sucking and blood-consuming parasites oral administration of a parasiticidal agent

Publications (1)

Publication Number Publication Date
UA102565C2 true UA102565C2 (ru) 2013-07-25

Family

ID=42073871

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201105519A UA102565C2 (ru) 2008-10-03 2009-09-30 Фармацевтическая композиция для системного лечения инвазии паразитов, которые сосут кровь или кормятся кровью, которая как антипаразитический препарат содержит имидаклоприд

Country Status (28)

Country Link
US (2) US9820977B2 (ru)
EP (1) EP2349265B1 (ru)
JP (3) JP6110065B2 (ru)
KR (3) KR20110067048A (ru)
CN (2) CN107041887A (ru)
AU (1) AU2009298541B2 (ru)
BR (1) BRPI0920434B1 (ru)
CA (1) CA2736263C (ru)
CL (1) CL2011000713A1 (ru)
CO (1) CO6361913A2 (ru)
DK (1) DK2349265T3 (ru)
EC (1) ECSP11011023A (ru)
ES (1) ES2588152T3 (ru)
HR (1) HRP20161082T1 (ru)
HU (1) HUE030412T2 (ru)
IL (1) IL211624B (ru)
MX (1) MX2011003415A (ru)
NI (1) NI201100067A (ru)
NZ (1) NZ592010A (ru)
PE (1) PE20110395A1 (ru)
PL (1) PL2349265T3 (ru)
PT (1) PT2349265T (ru)
RU (1) RU2526169C2 (ru)
SI (1) SI2349265T1 (ru)
SV (1) SV2011003871A (ru)
UA (1) UA102565C2 (ru)
WO (1) WO2010039892A1 (ru)
ZA (1) ZA201102077B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130035303A1 (en) * 2010-04-22 2013-02-07 Genesis Laboratories, Inc. Compositions and methods for control of sand flies and other blood sucking insects
CA2780119A1 (en) * 2011-06-16 2012-12-16 Daniel Kouri Capsule for oral pet medicine
AU2013245011B2 (en) * 2012-04-04 2017-11-23 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
EP3389628A4 (en) 2015-12-19 2019-08-07 Dixit, Manesh A. PHARMACEUTICAL FORMULATIONS OF MOUSE CHEESE TABLETS
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
EP3532041A4 (en) * 2016-10-31 2020-06-24 The Scripps Research Institute METHOD AND COMPOSITIONS FOR PREVENTING VECTOR-INDUCED DISEASE TRANSMISSION
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
EP3820870A1 (en) 2018-07-09 2021-05-19 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
CN113260419A (zh) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 吲唑基氰基乙基氨基化合物、其组合物、其制备方法和其使用方法
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
KR102659363B1 (ko) 2020-05-26 2024-04-22 주식회사 경보제약 동물에서의 기생충 감염 질환을 치료 또는 예방하기 위한 수의학적 구강붕해필름 제제
JP2023528822A (ja) 2020-05-29 2023-07-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性複素環式化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4419814A1 (de) * 1994-06-07 1995-12-14 Bayer Ag Endoparasitizide
US6140350A (en) 1998-06-08 2000-10-31 Sumitomo Chemical Company, Limited Method for controlling ectoparasites
JP4538863B2 (ja) * 1998-06-08 2010-09-08 住友化学株式会社 寄生虫の駆除方法
JP2000062271A (ja) 1998-08-17 2000-02-29 Murata Mach Ltd 記録装置
BR0013116B1 (pt) 1999-08-12 2013-01-22 formulaÇÕes orais de dose énica para controlar infestaÇço por ectoparasita em animais de estimaÇço, e seu uso.
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
JP4972843B2 (ja) 2000-11-09 2012-07-11 住友化学株式会社 動物外部寄生虫防除用経皮投与剤
CN1386420A (zh) 2001-05-22 2002-12-25 王玉万 一种含吡虫啉的宠物用抗寄生虫药
UA80096C2 (en) 2001-07-05 2007-08-27 Mikkel Sa Fencing for preventing insects to enter
JP2005515215A (ja) 2001-12-21 2005-05-26 ローディア インコーポレイティド 成分を懸濁させるための安定な界面活性剤組成物
US7943160B2 (en) 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
MXPA05012791A (es) 2003-05-25 2006-02-22 Wang Yuwan Formulacion sostenida que contiene dimeticona.
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
US20050234119A1 (en) 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
MX2007005617A (es) 2004-11-11 2007-07-09 Merial Ltd Derivados de vinilaminopirazol como pesticidas.
UY28617A1 (es) * 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
MX2007008837A (es) 2005-01-21 2008-01-22 Merial Ltd Compuestos quimicos, procesos para su preparacion y uso de los mismos.
TWI412322B (zh) * 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds

Also Published As

Publication number Publication date
EP2349265A4 (en) 2012-10-24
RU2526169C2 (ru) 2014-08-20
PL2349265T3 (pl) 2017-01-31
KR101787917B1 (ko) 2017-10-18
HUE030412T2 (hu) 2017-05-29
ES2588152T3 (es) 2016-10-31
RU2011117203A (ru) 2012-11-10
KR20110067048A (ko) 2011-06-20
BRPI0920434B1 (pt) 2021-07-27
JP2012504636A (ja) 2012-02-23
AU2009298541A1 (en) 2010-04-08
KR101903313B1 (ko) 2018-10-01
JP2018127468A (ja) 2018-08-16
EP2349265B1 (en) 2016-05-25
DK2349265T3 (en) 2016-09-05
BRPI0920434A2 (pt) 2015-12-22
MX2011003415A (es) 2011-08-12
SV2011003871A (es) 2011-08-22
AU2009298541B2 (en) 2015-03-26
PE20110395A1 (es) 2011-06-19
IL211624A0 (en) 2011-05-31
NZ592010A (en) 2012-07-27
ZA201102077B (en) 2012-12-27
US20100087492A1 (en) 2010-04-08
CO6361913A2 (es) 2012-01-20
ECSP11011023A (es) 2011-06-30
EP2349265A1 (en) 2011-08-03
JP2016179983A (ja) 2016-10-13
CA2736263A1 (en) 2010-04-08
JP6388890B2 (ja) 2018-09-12
WO2010039892A8 (en) 2011-03-24
HRP20161082T1 (hr) 2016-10-21
CN107041887A (zh) 2017-08-15
IL211624B (en) 2018-01-31
CA2736263C (en) 2020-01-14
US9820977B2 (en) 2017-11-21
KR20160011711A (ko) 2016-02-01
JP6110065B2 (ja) 2017-04-05
CN102170880A (zh) 2011-08-31
KR20170118235A (ko) 2017-10-24
SI2349265T1 (sl) 2016-10-28
NI201100067A (es) 2012-03-15
WO2010039892A1 (en) 2010-04-08
CL2011000713A1 (es) 2011-08-26
PT2349265T (pt) 2016-08-31
US20180078537A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
UA102565C2 (ru) Фармацевтическая композиция для системного лечения инвазии паразитов, которые сосут кровь или кормятся кровью, которая как антипаразитический препарат содержит имидаклоприд
TN2014000336A1 (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
UA106199C2 (ru) Производные аминобензамида как агенты, пригодные для использования для борьбы с паразитами животных
SG169369A1 (en) Inhibitors of e1 activating enzymes
PL2081547T3 (pl) Postać galenowa do podawania składników czynnych poprzez śluzówkę
MX2010014041A (es) Una forma cristalina de posaconazol.
MX2009007337A (es) Indazoles sustituidos con 5-piridinona.
EP2045251A4 (en) COMPOUNDS WHICH CAN INCLUDE THE UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
RS54904B1 (sr) Antibakterijske farmaceutske kompozicije
EP2012751A4 (en) NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
WO2005112633A3 (en) Compounds and compositions for delivering active agents
MX2010006284A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal.
MX2009008084A (es) Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
EP2142549A4 (en) ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE
AP3573A (en) Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
TW200738627A (en) Trialkylsilyl-indoles
WO2010019611A3 (en) Bridged polycyclic compound based compositions for topical and oral applications
NZ711847A (en) Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
WO2007138468A3 (en) Processes for the preparation of lansoprazole
MX2010004859A (es) Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso.
MX2008002272A (es) Compuestos de ciclopropilo y composiciones para suministrar agentes activos.
WO2009124723A3 (en) Novel aureothin derivatives
MX2010014248A (es) Nuevos antibioticos de trinem e inhibidores de beta-lactamasas.